How Doxycycline Disarms Bacteria: Exeter Scientists Reveal the Mechanism

Researchers at the University of Exeter discovered two new mechanisms for how the antibiotic doxycycline works against bacteria, including stacking molecules to block the ribosome exit channel and reconfiguring ribosomes into an inactive state. The findings, published in Nature Communications, reveal how the drug disarms pathogens like Coxiella burnetii and could guide the design of a new generation of treatments against resistant infections.

How Doxycycline Blocks Bacterial Growth in Coxiella burnetii

Cells build proteins using cellular machines called ribosomes, which translate genetic instructions carried by mRNA molecules. Newly constructed proteins exit this machine through a specific channel. According to a study led by the University of Exeter’s Living Systems Institute, antibiotic molecules stack upon each other to block this ribosome exit channel in Coxiella burnetii.

This stacking action prevents the translation of mRNA molecules, halting protein production entirely and stopping the bacteria from growing and reproducing. Researchers utilized advanced electron microscopy to observe these molecular structures in unprecedented detail. While scientists already knew doxycycline targeted bacterial ribosomes by blocking tRNA binding at the decoding center, this structural stacking represents an entirely new mechanism of action.

Discovering a Second Mechanism in E. coli

Beyond the findings in animal-borne pathogens, the Exeter research team observed an additional mechanism when examining the more commonly studied bacterium E. coli. According to the study findings, a single doxycycline molecule can radically reconfigure the ribosome into an inactive state that scientists had never seen before.

Dr. William Stuart, lead author of the study, noted that the results caught the research team by surprise, explaining that they had no idea such a mechanism would emerge to explain the high efficacy of the drug. Professor Nicholas Harmer, who led the research at the University of Exeter’s Living Systems Institute, stated that the team now needs to investigate whether these insights can be expanded to other forms of bacteria that exhibit resistance to current antibiotics.

The Global Search for Next-Generation Antibiotics

The search for new antimicrobial treatments remains an international research priority. Bacterial evolution has driven increasing rates of antibiotic resistance, turning previously treatable infections into potentially deadly threats. Funding for the Exeter study came from the UKRI Biotechnology and Biological Sciences Research Council and the Defence Science and Technology Laboratory.

By mapping these previously unknown pathways using advanced cryo-electron microscopy, scientists hope to harness these exact mechanisms to engineer potent future antibiotics. The observation of the reconfigured inactive ribosome provides a concrete blueprint for chemists working to combat diseases that resist current medical interventions.

Frequently Asked Questions